State Grid Ningxia Electric Power Co, Ltd Guyuan Branch: Innovative Work Methods to Solve Challenges
GUYUAN, China, Dec. 17, 2024 /PRNewswire/ -- During the turning process, pay attention to the angle to prevent tipping. Recently, at the construction site of the 110kV interval expansion project of the 330kV substation in Qingshuihe, operators from...
5,700 Charging Ports to "Power Up" Residents' Green Travels
KUITUN, China, Dec. 6, 2024 /PRNewswire/ -- "Sir, you shouldn't charge your electric bike by 'hanging a wire' from your home. This will not only affect the electricity usage in the community but also pose risks of fire or explosion for the battery....
GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment
YONGIN, South Korea, Nov. 26, 2024 /PRNewswire/ -- GC Biopharma and Novel Pharma today announced that the first patient in the US has been dosed in multinational clinical trial with 'GC1130A', an innovative new drug for Sanfillippo syndrome type A...
Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy
Hanmi unveils tiral in progress poster on BH3120 at the Society for Immunotherapy of Cancer (SITC) in the U.S. Phase 1 trial is progressing smoothly, with no dose-limiting toxicity observed Phase 1 trial evaluating the combination of BH3120 and...
The "Navigator" unmanned aerial vehicle (UAV): Flying out a new picture for power grid operations
XUZHOU, China, Nov. 21, 2024 /PRNewswire/ -- At the Tuolan 110-kilovolt transmission line project site in Xuzhou, Jiangsu Province, the "Navigator" unmanned aerial vehicle (UAV) is pioneering a new era in safety and efficiency for power grid...
InxMed FAK Inhibitor Ifebemtinib Received Breakthrough Therapy Designation by China National Medical Products Administration for First-Line Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation
NANJING, China, Nov. 21, 2024 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company developing innovative therapies against cancer treatment resistance and metastasis, announced that China National Medical Products Administration...